U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07821177) titled 'Bladder Preservation or Cystectomy for MIBC' on Sept. 02.
Brief Summary: In this research study, investigators will assess whether it is feasible to use information from the genes of a tumor combined with evaluation of the tumor response to systemic therapy to determine if bladder sparing chemoradiation can be used or if surgery to remove the bladder, or radical cystectomy, is needed.
Study Start Date: Sept. 02
Study Type: INTERVENTIONAL
Condition:
Muscle-Invasive Bladder Carcinoma
Bladder Cancer
Urothelial Carcinoma
Intervention:
DRUG: Gemzar
Nucleoside metabolic inhibitor, 200 mg single-dose vial, via intravenous infusion ...